Properties
Description
Erlotinib mesylate is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR.
Molecular Formula
C23H27N3O7S
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Erlotinib mesylate is applied in research to examine its EGFR tyrosine kinase inhibition and effects on tumor growth.
